Demedici Corporation

Source Check Matrix

What Has Been Verified vs. What Needs Human Review

Source and Resolution Links

Finish the Investigation Outside Our Dataset

When the answer lives with the IRS, ProPublica, Candid, Charity Navigator, or the nonprofit itself, NonprofitSpending links out instead of trapping the user on a partial answer.

Workflow Engine

Queries We Should Resolve, Not Just Answer

Search Console demand points to task completion. Each workflow can run calculations, source checks, external lookups, comparisons, and report/export capture around this nonprofit.

Search Intent Cockpit

Demedici Corporation Form 990, Revenue, CEO Pay, and IRS Filing Signals

Demedici Corporation is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Demedici Corporation in one place.

Is Demedici Corporation Legit?

Some Concerns

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

IRS 990 Data Cockpit

Where the Money Comes From and Where It Goes

Across stored filings, Demedici Corporation shows contribution history pending. Next enrichment targets: revenue-source fields, IRS BMF classification.

Decision Cockpit

One-Stop Donor, Research, and Peer Context Hub

Donation Decision Flow

From Trust Check to Better Alternatives

Alternative Shopping

Similar Nonprofits Donors Should Compare

Browse the full Education peer market in New Jersey →

Next Best Actions

Keep the Investigation Moving

Research Workflow

Turn this Form 990 profile into a donor-ready report

Request a concise report for Demedici Corporation with revenue, expenses, executive compensation, red flags, peer context, and IRS source links. You can also request CSV exports or watchlist updates for future filings.

Early access request only. Reports and exports are informational and based on public IRS records, not financial or legal advice.

Demedici Corporation directs 75% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.

About Demedici Corporation

Demedici Corporation (EIN: 10818965) is a nonprofit organization based in Marlton, NJ, classified under NTEE code B112. The organization reported total revenue of $1.0M and total assets of $16.1M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Demedici Corporation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

Demedici Corporation is a mid-size nonprofit that has been operating for 22 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 2.2%.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

Financial Health Grade: A

In 2023, Demedici Corporation reported a surplus of $479K with revenue exceeding expenses, holds 383.2 months of operating reserves (strong position), has a debt-to-asset ratio of 59.6% (high leverage).

Financial Trends

Over 13 years of filings (2011–2023), Demedici Corporation's revenue has grown at a compound annual growth rate (CAGR) of 2.2%.

IRS Tax-Exempt Classification

Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.

AI Transparency Report

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Demedici Corporation with a Mission Score of 80 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

• admin: 15%
• programs: 75%
• fundraising: 10%

According to IRS 990 filings, Demedici Corporation allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

• The organization reported a surplus of $479K, with revenue exceeding expenses.
• Debt-to-asset ratio: 59.6%.

Executive Compensation Analysis

Demedici Corporation consistently reports 0% officer compensation across all provided filing periods, indicating that no salaries or other compensation are paid to its officers, which is highly unusual for an organization of its size and asset base ($16 million).

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of Demedici Corporation's IRS 990 filings:

• Significant increase in liabilities from $43,504 in 2020 to $9,319,616 in 2023 without clear explanation.
• Lack of detailed expense breakdown (program, admin, fundraising) in the provided data, hindering efficiency analysis.
• Consistent 0% officer compensation for an organization with over $15 million in assets, which is highly unusual and warrants further investigation into operational structure.

Strengths

The following positive indicators were identified for Demedici Corporation:

• Consistent revenue growth, from $394,109 in 2014 to $968,918 in 2023.
• Strong asset growth, increasing from $2.3 million in 2014 to over $15.6 million in 2023.
• Expenses generally kept well below revenue, indicating sound financial management in most periods (e.g., 2023 revenue $968,918 vs. expenses $490,030).
• No reported officer compensation, suggesting a strong commitment to directing funds to the mission.

Frequently Asked Questions about Demedici Corporation

Filing History

IRS 990 filing history for Demedici Corporation showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2011–2023), Demedici Corporation's revenue has grown by 29.8%, moving from $746K to $969K. Total assets increased by 574.9% over the same period, from $2.3M to $15.6M. Total functional expenses rose by 45.9%, from $336K to $490K. In its most recent filing year (2023), Demedici Corporation reported a surplus of $479K, with revenue exceeding expenses. The organization holds $9.3M in liabilities against $15.6M in assets (debt-to-asset ratio: 59.6%), resulting in net assets of $6.3M.

Year-by-Year Financial Summary

• 2023: Revenue of $969K, expenses of $490K, and assets of $15.6M (revenue +2.9% year-over-year).
• 2022: Revenue of $942K, expenses of $429K, and assets of $15.4M (revenue +13.1% year-over-year).
• 2021: Revenue of $833K, expenses of $300K, and assets of $11.2M (revenue +3.8% year-over-year).
• 2020: Revenue of $802K, expenses of $423K, and assets of $4.8M (revenue +0.9% year-over-year).
• 2019: Revenue of $795K, expenses of $330K, and assets of $4.4M (revenue +6.0% year-over-year).
• 2018: Revenue of $750K, expenses of $271K, and assets of $4.0M (revenue +0.6% year-over-year).
• 2017: Revenue of $746K, expenses of $217K, and assets of $3.6M (revenue +6.7% year-over-year).
• 2016: Revenue of $699K, expenses of $208K, and assets of $3.1M (revenue +10.6% year-over-year).
• 2015: Revenue of $632K, expenses of $241K, and assets of $2.6M (revenue +60.4% year-over-year).
• 2014: Revenue of $394K, expenses of $466K, and assets of $2.4M (revenue +0.1% year-over-year).
• 2013: Revenue of $394K, expenses of $510K, and assets of $2.4M (revenue -48.2% year-over-year).
• 2012: Revenue of $760K, expenses of $516K, and assets of $2.5M (revenue +1.8% year-over-year).
• 2011: Revenue of $746K, expenses of $336K, and assets of $2.3M.

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for Demedici Corporation:

Data Sources and Methodology

This transparency report for Demedici Corporation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.